|
1
|
DeSantis C, Ma J, Bryan L and Jemal A:
Breast cancer statistics, 2013. CA Cancer J Clin. 64:52–62. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li Y, Cai B, Shen L, Dong Y, Lu Q, Sun S,
Liu S, Ma S, Ma PX and Chen J: MiRNA-29b suppresses tumor growth
through simultaneously inhibiting angiogenesis and tumorigenesis by
targeting Akt3. Cancer Lett. 397:111–119. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sun G, Sun L, Liu Y, Xing H and Wang K:
Her-2 expression regulated by downregulation of miR-9 and which
affects chemotherapeutic effect in breast cancer. Cancer Gene Ther.
24:194–202. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liu Y, Li X, Zhu S, Zhang JG, Yang M, Qin
Q, Deng SC, Wang B, Tian K, Liu L, et al: Ectopic expression of
miR-494 inhibited the proliferation, invasion and chemoresistance
of pancreatic cancer by regulating SIRT1 and c-Myc. Gene Ther.
22:729–738. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li X, Deng SJ, Zhu S, Jin Y, Cui SP, Chen
JY, Xiang C, Li QY, He C, Zhao SF, et al: Hypoxia-induced
lncRNA-NUTF2P3-001 contributes to tumorigenesis of pancreatic
cancer by derepressing the miR-3923/KRAS pathway. Oncotarget.
7:6000–6014. 2016.PubMed/NCBI
|
|
6
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Winter J, Jung S, Keller S, Gregory RI and
Diederichs S: Many roads to maturity: microRNA biogenesis pathways
and their regulation. Nat Cell Biol. 11:228–234. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang B, Zou A, Ma L, Chen X, Wang L, Zeng
X and Tan T: miR-455 inhibits breast cancer cell proliferation
through targeting CDK14. Eur J Pharmacol. 807:138–143. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li P, Xu T, Zhou X, Liao L, Pang G, Luo W,
Han L, Zhang J, Luo X, Xie X and Zhu K: Downregulation of miRNA-141
in breast cancer cells is associated with cell migration and
invasion: Involvement of ANP32E targeting. Cancer Med. 6:662–672.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhao M, Ang L, Huang J and Wang J:
MicroRNAs regulate the epithelial-mesenchymal transition and
influence breast cancer invasion and metastasis. Tumour Biol.
39:10104283176916822017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen Z, Liu S, Tian L, Wu M, Ai F, Tang W,
Zhao L, Ding J, Zhang L and Tang A: miR-124 and miR-506 inhibit
colorectal cancer progression by targeting DNMT3B and DNMT1.
Oncotarget. 6:38139–38150. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sun Y, Ai X, Shen S and Lu S:
NF-κB-mediated miR-124 suppresses metastasis of non-small-cell lung
cancer by targeting MYO10. Oncotarget. 6:8244–8254. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Peng XH, Huang HR, Lu J, Liu X, Zhao FP,
Zhang B, Lin SX, Wang L, Chen HH, Xu X, et al: MiR-124 suppresses
tumor growth and metastasis by targeting Foxq1 in nasopharyngeal
carcinoma. Mol Cancer. 13:1862014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cai WL, Huang WD, Li B, Chen TR, Li ZX,
Zhao CL, Li HY, Wu YM, Yan WJ and Xiao JR: microRNA-124 inhibits
bone metastasis of breast cancer by repressing Interleukin-11. Mol
Cancer. 17:92018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Du S, Li H, Sun X, Li D, Yang Y, Tao Z, Li
Q and Liu K: MicroRNA-124 inhibits cell proliferation and migration
by regulating SNAI2 in breast cancer. Oncol Rep. 36:3259–3266.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang Y, Chen L, Wu Z, Wang M, Jin F, Wang
N, Hu X, Liu Z, Zhang CY, Zen K, et al: miR-124-3p functions as a
tumor suppressor in breast cancer by targeting CBL. BMC Cancer.
16:8262016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Feng T, Shao F, Wu Q, Zhang X, Xu D, Qian
K, Xie Y, Wang S, Xu N, Wang Y and Qi C: miR-124 downregulation
leads to breast cancer progression via LncRNA-MALAT1 regulation and
CDK4/E2F1 signal activation. Oncotarget. 7:16205–16216.
2016.PubMed/NCBI
|
|
18
|
Liao XH, Xiang Y, Yu CX, Li JP, Li H, Nie
Q, Hu P, Zhou J and Zhang TC: STAT3 is required for
MiR-17-5p-mediated sensitization to chemotherapy-induced apoptosis
in breast cancer cells. Oncotarget. 8:15763–15774. 2016.
|
|
19
|
Wang N, Wei L, Huang Y, Wu Y, Su M, Pang
X, Wang N, Ji F, Zhong C, Chen T and Li B: miR520c blocks EMT
progression of human breast cancer cells by repressing STAT3. Oncol
Rep. 37:1537–1544. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu F, Zhang H and Song H: Upregulation of
MEK5 by Stat3 promotes breast cancer cell invasion and metastasis.
Oncol Rep. 37:83–90. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
McDaniel JM, Varley KE, Gertz J, Savic DS,
Roberts BS, Bailey SK, Shevde LA, Ramaker RC, Lasseigne BN, Kirby
MK, et al: Genomic regulation of invasion by STAT3 in triple
negative breast cancer. Oncotarget. 8:8226–8238. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xiang Y, Liao XH, Yu CX, Yao A, Qin H, Li
JP, Hu P, Li H, Guo W, Gu CJ and Zhang TC: MiR-93-5p inhibits the
EMT of breast cancer cells via targeting MKL-1 and STAT3. Exp Cell
Res. 357:135–144. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kertesz M, Iovino N, Unnerstall U, Gaul U
and Segal E: The role of site accessibility in microRNA target
recognition. Nat Genet. 39:1278–1284. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Watson IR, Takahashi K, Futreal PA and
Chin L: Emerging patterns of somatic mutations in cancer. Nat Rev
Genet. 14:703–718. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ilamathi M, Prabu PC, Ayyappa KA and
Sivaramakrishnan V: Artesunate obliterates experimental
hepatocellular carcinoma in rats through suppression of
IL-6-JAK-STAT signalling. Biomed Pharmacother. 82:72–79. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Siveen KS, Sikka S, Surana R, Dai X, Zhang
J, Kumar AP, Tan BK, Sethi G and Bishayee A: Targeting the STAT3
signaling pathway in cancer: Role of synthetic and natural
inhibitors. Biochim Biophys Acta. 1845:136–154. 2014.PubMed/NCBI
|
|
29
|
Tkach M, Rosemblit C, Rivas MA, Proietti
CJ, Díaz Flaqué MC, Mercogliano MF, Beguelin W, Maronna E, Guzmán
P, Gercovich FG, et al: p42/p44 MAPK-mediated Stat3Ser727
phosphorylation is required for progestin-induced full activation
of Stat3 and breast cancer growth. Endocr Relat Cancer. 20:197–212.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Banerjee K and Resat H: Constitutive
activation of STAT3 in breast cancer cells: A review. Int J Cancer.
138:2570–2578. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Thakur R, Trivedi R, Rastogi N, Singh M
and Mishra DP: Inhibition of STAT3, FAK and Src mediated signaling
reduces cancer stem cell load, tumorigenic potential and metastasis
in breast cancer. Sci Rep. 5:101942015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Baek D, Villén J, Shin C, Camargo FD, Gygi
SP and Bartel DP: The impact of microRNAs on protein output.
Nature. 455:64–71. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bird A: DNA methylation patterns and
epigenetic memory. Genes Dev. 16:6–21. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen X and Huang L: LRSSLMDA: Laplacian
regularized sparse subspace learning for MiRNA-disease association
prediction. PLoS Comput Biol. 13:e10059122017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chen X, Yin J, Qu J and Huang L: MDHGI:
Matrix decomposition and heterogeneous graph inference for
miRNA-disease association prediction. PLoS Comput Biol.
14:e10064182018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chen X, Xie D, Wang L, Zhao Q, You ZH and
Liu H: BNPMDA: Bipartite network projection for MiRNA-disease
association prediction. Bioinformatics. 34:3178–3186. 2018.
View Article : Google Scholar : PubMed/NCBI
|
